SEC Form 4 · accession 0000899243-17-016119
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bill Roeschlein
Officer — Chief Financial Officer
Period of report
Jun 11, 2017
Accepted (ET)
Jun 12, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.90 | Jun 11, 2017 | A | 250,000 | A | — | Jun 10, 2027 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The option grant vests monthly over 4 years from the date of grant.